Submitted manuscript of a guidance document outlining lessons learned for conducting drug utilization and medication safety studies based on secondary data sources in pregnancy using the ConcePTION pipeline (D1.7)

Amanda J. Neville(University of Ferrara), Marie‐Laure Kürzinger, Maria Loane(University of Ulster), Joanne Given(University of Ulster), Olga Paoletti(Agenzia Regionale di Sanità della Toscana), Helen Dolk(University of Ulster), Joan K. Morris(St George's, University of London), F Coste(Lundbeck (Denmark)), Marco Manfrini(University of Padua), Anja Geldhof, Vjola Hoxhaj(Utrecht University), Maarit K. Leinonen(University of Helsinki), Cori Campbell(University Medical Center Utrecht), Julie Scotto(Bristol-Myers Squibb (United States)), Marie Beslay(Université Toulouse III - Paul Sabatier), Miriam C J M Sturkenboom(Utrecht University), Sandra Lopez Leon(Novartis (United States)), sue jordan(Swansea University), Keele Wurst(GlaxoSmithKline (United States)), Vesa Martikainen, Yvonne Geissbühler, Anna-belle Beau(Centre Hospitalier Universitaire de Toulouse), Christine Damase-Michel, Ditte Mølgaar-Neislen(Statens Serum Institut), Constanza Lourdes Andaur Navarro(University Medical Center Utrecht), Hedvig Nordeng(Norwegian Institute of Public Health), Alexis A. Krumme(Brigham and Women's Hospital)
Zenodo (CERN European Organization for Nuclear Research)
December 13, 2024
Cited by 0


Related Papers